ATE482198T1 - Sitamaquintosylat zur behandlung von leishmaniase - Google Patents

Sitamaquintosylat zur behandlung von leishmaniase

Info

Publication number
ATE482198T1
ATE482198T1 AT07821013T AT07821013T ATE482198T1 AT E482198 T1 ATE482198 T1 AT E482198T1 AT 07821013 T AT07821013 T AT 07821013T AT 07821013 T AT07821013 T AT 07821013T AT E482198 T1 ATE482198 T1 AT E482198T1
Authority
AT
Austria
Prior art keywords
treatment
leishmaniasis
sitamaquintosylate
formula
disclosed
Prior art date
Application number
AT07821013T
Other languages
English (en)
Inventor
Andrew Searle
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of ATE482198T1 publication Critical patent/ATE482198T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/40—Nitrogen atoms attached in position 8
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT07821013T 2006-10-10 2007-10-08 Sitamaquintosylat zur behandlung von leishmaniase ATE482198T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0620005.9A GB0620005D0 (en) 2006-10-10 2006-10-10 Compounds
PCT/EP2007/060640 WO2008043726A1 (en) 2006-10-10 2007-10-08 Sitamaquine tosylate for the treatment of leishmaniasis

Publications (1)

Publication Number Publication Date
ATE482198T1 true ATE482198T1 (de) 2010-10-15

Family

ID=37491186

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07821013T ATE482198T1 (de) 2006-10-10 2007-10-08 Sitamaquintosylat zur behandlung von leishmaniase

Country Status (6)

Country Link
US (1) US20100076017A1 (de)
EP (1) EP2081906B1 (de)
AT (1) ATE482198T1 (de)
DE (1) DE602007009413D1 (de)
GB (1) GB0620005D0 (de)
WO (1) WO2008043726A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20240091231A1 (en) * 2022-08-31 2024-03-21 Astrazeneca Ab Pharmaceutical formulations

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4209519A (en) * 1978-03-13 1980-06-24 The United States Of America As Represented By The Secretary Of The Army Anti-leishmanial lepidine derivatives
US4659708A (en) * 1980-09-02 1987-04-21 The United States Of America As Represented By The Secretary Of The Army Anti-leishmanial lepidine derivatives
GB9521004D0 (en) 1995-10-13 1995-12-13 Smithkline Beecham Plc Process

Also Published As

Publication number Publication date
EP2081906A1 (de) 2009-07-29
WO2008043726A1 (en) 2008-04-17
US20100076017A1 (en) 2010-03-25
EP2081906B1 (de) 2010-09-22
DE602007009413D1 (de) 2010-11-04
GB0620005D0 (en) 2006-11-22

Similar Documents

Publication Publication Date Title
CY1122522T1 (el) Μετα αρσενικωδες νατριο για χρηση στην αγωγη του πολλαπλου μυελωματος
CY1109911T1 (el) Πυρρολοβενζοδιαζεπινες
DK1853602T3 (da) Kemiske forbindelser
CY1108275T1 (el) Χημικες ενωσεις
EP1876990A4 (de) Behandlung von zähnen mit alignern
NO20080129L (no) Fremgangsmate for fremstilling av dihydrokinazoliner
MA33803B1 (fr) Inhibiteur de bromodomaine de benzodiazépine
EA201100037A1 (ru) Органические соединения
EA201070422A1 (ru) Производные оксадиазола
EP1755661A4 (de) Verwendung von gelsolin zur behandlung von infektionen
EA201170832A1 (ru) Пуриновые соединения
DE602006020327D1 (de) 2-phenoxy-n-(1,3,4-thiadizol-2-yl)pyridin-3-aminder-hemmer zur behandlung thromboembolischer erkrankungen
NO20071127L (no) Triazoloftalaziner
DE602007005697D1 (de) Verwendung von carrageenan zur behandlung von rhinovirus-infektionen
EA200801997A1 (ru) Новые соединения
EA200701396A1 (ru) Триазолофталазины в качестве ингибиторов pde-2
UY29612A1 (es) Compuestos quimicos ii
EP2135858A4 (de) Zusammensetzung zur behandlung von infektionserkrankungen
ATE429218T1 (de) Pinolensäure zur behandlung von übergewicht
TW200630367A (en) Substituted adenines and the uses thereof
EA200900780A1 (ru) Аналоги эпотилона, модифицированные в положениях c12-c13, как противораковые лекарственные средства
MA28707B1 (fr) Utilisation de 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines substituees lors du traitement de nausees et de vomissements
UY30788A1 (es) Compuestos quimicos
ATE472324T1 (de) Isosorbid-mononitrat-derivate zur behandlung von okularer hypertonie
DE602005015963D1 (de) Estergebundene makrolide, die sich für die behandlung von mikrobiellen infektionen eignen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties